Join Medicilon at American College of Toxicology (ACT) 2024

American College of Toxicology (ACT) 2024 kicks off on November 17 2024 at JW Marriott Austin, Austin, Texas. Maybe we can work together and Medicilon can be a great partner! Come and chat with our American team at booth #117!

About American College of Toxicology (ACT)

ACT is a global community of professional scientists representing the pharmaceutical and biotech industries, regulatory agencies, contract research organizations, academia, and consulting firms. The mission of the College is to “Educate, Lead, and Serve” scientists by providing a forum to promote an exchange of information and perspectives on safety assessment and new developments related to applied toxicological sciences.

About Medicilon

Medicilon is a leading global integrated pharmaceutical R&D service contract research organization (CRO), providing a full range of one-stop preclinical R&D services, in compliance with Chinese and international regulatory filing standards, to pharmaceutical companies and research institutions world-wide. With our experience in serving domestic and foreign biomedical industries, we have built an integrated platform covering key technologies in drug discovery, pharmaceutical research, and preclinical research, to provide a comprehensive preclinical R&D service for the global biomedical industry.

20 Years of Excellence

500+ IND Approved by FDA, NMPA, EMA, and TGA

2000+ Active Clients Worldwide

2600+ Scientists & Research Staff

85,000+ m² Lab Space

At Medicilon, we are dedicated to support our clients develop their research and discovery programs from initial concept through the IND filing phase. Our services span across medicinal chemistry, biology, API, CMC, formulation, and preclinical studies. We provide flexible business models, including stand-alone Fee for Services (FFS) and fully integrated FTE services. In addition, our facilities are GLP/GMP compliant, US-FDA, China NMPA and AAALAC accredited. All study reports can be presented in SEND format, supporting dual filing of IND applications in the US, EU, and China. 

Medicilon Non-clinical Toxicology Studies Services (GLP and non-GLP)

Medicilon offers comprehensive toxicology study services designed to assess the safety profile and potential risks of pharmaceutical compounds. Our expert team collaborates closely with clients to tailor studies according to regulatory requirements and project-specific needs. Our state-of-the-art facilities, advanced platform, experienced scientists, and commitment to quality ensure that clients receive high quality, reliable, and regulatory-compliant GLP toxicology data to support the development of safe and effective pharmaceutical products. Medicilon has been at the forefront of pharmaceutical R&D for over 20 years. We have supported more than 2,000 global clients and have contributed to the IND approval of more than 490 drugs.

01  Toxicology Services

❖Single and repeated-dose toxicity studies

❖Reproductive/developmental and juvenile toxicity studies

❖Genotoxicity studies

❖Toxicokinetic studies

❖Safety pharmacology research

❖Immunogenicity studies

❖Local tolerance studies

❖Carcinogenicity studies

02  Histopathology Studies

❖H&E staining

❖Special staining

❖Immunohistochemistry (IHC)

❖Tissue cross-reactivity (TCR)

03  Clinical Pathology Studies

❖Hematology analysis

❖Urinalysis

❖Clinical biochemistry analysis

❖Hemocoagulation analysis

❖Lymphocyte phenotyping

04 New Drug Delivery Technology

❖Inhalation formulation safety assessment

❖Ophthalmology safety assessment